Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-07-26
- Last Posted Date
- 2016-02-26
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 1075
- Registration Number
- NCT00123773
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-07-26
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 23
- Registration Number
- NCT00123747
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection
Phase 2
Terminated
- Conditions
- First Posted Date
- 2005-07-26
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 199
- Registration Number
- NCT00123799
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy
Withdrawn
- Conditions
- First Posted Date
- 2005-07-26
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- AHS Cancer Control Alberta
- Registration Number
- NCT00123812
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-07-26
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 10838
- Registration Number
- NCT00123760
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma
Phase 2
Terminated
- Conditions
- First Posted Date
- 2005-07-26
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 4
- Registration Number
- NCT00123786
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 13
- Registration Number
- NCT00122239
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer
Terminated
- Conditions
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2016-02-26
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 83
- Registration Number
- NCT00122265
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Β© Copyright 2024. All Rights Reserved by MedPath